Picture of Acotec Scientific Holdings logo

6669 Acotec Scientific Holdings Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapFalling Star

Annual cashflow statement for Acotec Scientific Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-67.270.314.552.6122
Depreciation
Amortisation
Non-Cash Items67-5.46-5.47-1.244.14
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-19.9-153-68.11.45-29.7
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-10.5-68.8-12.9103150
Capital Expenditures-21.2-46.7-79.7-56-26.2
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.762-2.47-240101-491
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-20.5-49.2-31945-518
Financing Cash Flow Items-67.2-1.76-9.96-11.5-10.3
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1,024-32.9-23.2-35.223.5
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash990-151-349114-352